TY - JOUR T1 - Is the Current N95 Respirator Filtration Efficiency Test Sufficient for Evaluating Protection Against Submicrometer Particles Containing SARS-CoV-2? JF - medRxiv DO - 10.1101/2020.05.14.20102327 SP - 2020.05.14.20102327 AU - Changjie Cai AU - Evan L. Floyd AU - Kathleen A. Aithinne AU - Toluwanimi Oni Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/05/18/2020.05.14.20102327.abstract N2 - Previous researchers measured the Overall Filtration Efficiency using sodium chloride testing aerosol with aerosol photometer to analyze the reuse of respirators after sterilization. However, this study showed that the Overall Filtration Efficiency would significantly overestimate the respirators’ ability to protect against submicrometer particles containing SARS-CoV-2. For example, after three cycle H2O2 vaporous sterilizations, the most penetrating particle size for the N95 level respirators was from 250 nm – 500 nm, which carried the peak concentration of the SARS-CoV-2 in hospitals. The Size Specific Filtration Efficiency (250 nm – 500 nm) dropped to 56%±4%, however, the Overall Filtration Efficiency was still 86%±5%. In order to protect health care personnel adequately, we recommend measuring the Size Specific Filtration Efficiency to evaluate the reuse of respirators.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was made possible by support from the Oklahoma State Department of Health to establish this testing program, by the supply chain logistics group at the University of Oklahoma Medical Center who provided the respirators and sterilization treatments, by the University of Oklahoma Health Sciences Center VPR’s office through a COVID19 Rapid Response pilot grant, and by the student volunteers that assisted with data collection.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript is available. ER -